Thank you, Sascha. I'll spend the next few minutes discussing our Q2 2022 financial results. Please turn to Slide 8, and I will summarize the main line items from our Q2 P&L. First off, revenue. I am pleased to report strong revenue growth in the second quarter, which grew 93% to $64.4 million from $33.4 million in Q2 2021. I will take you through the geographic breakdown in a later slide, but I would like to highlight that this marks the sixth quarter in a row that we have shown substantial revenue growth over the same quarter in the prior year. In fact, on a percentage basis, revenue has grown double or triple digits for each quarter since Q1 2021. On a year-to-date basis, revenue was $101.1 million, up 109.2% from $48.3 million in the prior 6-month period. We posted gross profit of $4.8 million in Q2 2022 compared to gross loss of $6.8 million in the prior period, an improvement of 171.5%. After adjusting for noncash settled share-based compensation expense in our cost of sales, adjusted gross profit was $6.7 million in Q2 2022 compared to adjusted gross loss of $6.8 million in Q2 2021. This translates into an adjusted gross margin of 10.4% in Q2 2022 compared to negative 20.3% in Q2 2021, a 30.7 percentage point improvement. I was pleased to see gross margin improve at a faster rate than revenues during the quarter despite higher raw material prices. This result underpins our efforts to improve our gross margin performance long term, and it will continue to be an area of focus for us going forward, especially as we plan for significantly higher customer deliveries in 2023. Operating expenses were $50.4 million in Q2 2022 compared to $15.8 million in Q2 2021. The largest contributor to the increased operating expenses was share-based compensation expense, which totaled $28.5 million in the quarter. Operating expenses also increased as the company continues to add headcount to support planned growth initiatives and also incurred additional expenses related to operating as a public company compared to the prior year period. As I mentioned previously, noncash share-based compensation expenses were a significant contributor to both the increase in GAAP operating expenses and operating losses. The large majority of share-based compensation expense relates to equity awards made in the years preceding our business combination last summer. Accounting rules require that those awards be expensed to our P&L over a 3-year period following the merger. We believe a more accurate representation of our financial performance especially as relating to cash operating expenses and operating loss is as illustrated in Slide 9. After adjusting for noncash stock-based compensation in SG&A, our adjusted operating expense in Q2 2022 was $21.7 million compared to $15.8 million in Q2 2021. GAAP net loss was $44.2 million in Q2 2022 compared to a net loss of $27.1 million in Q2 2021. After adjusting for noncash share-based compensation expense and changes in fair value of warrant liability and convertible notes, adjusted net loss was $14.9 million in Q2 2022 compared to $23.8 million in Q2 2021. Reconciliations of these non-GAAP metrics to the most comparable GAAP metrics are included in the tables at the end of our earnings press release. Slide 10 shows the geographic breakdown of our revenue for the 3- and 6-month periods ended June 30, 2022, compared to the prior year period. I am pleased to report that all 4 of our key geographies posted growth in Q2 2022 compared to Q2 2021. As you can see, the largest growth in revenues came from the Asia Pacific region ex China, equivalent to 231% growth compared to Q2 2021 and 310% growth for the first 6 months. India continues to be the biggest driver of growth for us in the Asia Pacific region. In addition, our China business continues to perform well, posting 57% growth during the quarter. Europe also posted a healthy 15% growth rate. Even though Europe's growth is currently lagging the other geographies, given the impacts from the war in Ukraine, we have some exciting projects coming up in the region, and we expect the growth rate to increase beginning in the second half of 2022 and with a very significant pickup starting in 2023. I will now take you through our funding position and the cash movement in Q2 2022, which is on Slide 11. We started the quarter with $471 million in cash, cash equivalents and restricted cash. Net cash used in operating activities during the quarter was $39 million, which is primarily due to increased accounts receivables, notes receivables and inventory due to our higher sales. In particular, April and May was slow months for shipments due to Shanghai port operations being restricted with COVID lockdown measures. This meant the majority of our shipments occurred in June, which pushed many payment and collection dates into future quarters. Our CapEx spend on Huzhou 3.1 and Clarksville 1A in Q2 2022 totaled $23 million, and we also had capital expenditures totaling $4 million, that mainly relate to improvements to our existing facilities and R&D projects. Our current estimates are that capital expenditure for the second half will be in the range of $180 million to $220 million and will primarily be used for our capacity expansion projects. As our payments are determined by construction and equipment delivery milestones, it may be the case that some of these payments are brought forward or pushed out into 2023. We closed the quarter in a very strong cash position of approximately $396.9 million in cash, cash equivalents and restricted cash. We expect to add modest levels of debt given the low leverage on our balance sheet and as our fixed asset base grows. For example, with 99% of the Huzhou building complete and this facility already backed by very strong cash flows from our customers, we have been in discussions with a syndicate of local banks to arrange a project finance facility. We expect this will -- we expect it to be available for drawdown from late August. With the benefit of this debt financing, we expect to close the year with at least $250 million in cash. As the Clarksville construction progresses and receives equipment, it too will also support debt financing along the lines we're putting in place for the Huzhou expansion. Accordingly, all our capacity expansion projects are fully funded and the business is in a very solid balance sheet position to execute on its aggressive sales plan for 2023. Lastly, please see Slide 12 for an overview of our Huzhou 3.1 expansion project. The new capacity this brings online for our new high-power and high-energy cells supports our 2023 growth targets with over half of the available capacity already allocated to customers across Europe, Asia Pacific and China, who have entered into multiyear framework agreements with us. Huzhou remains on schedule with the exterior of the building at 99% completion. We posted drone footage to our social media accounts earlier this week with aerial views of the facilities. We expect equipment to start being delivered this month with production ramp-up beginning in Q4 2022. We currently expect Clarksville to begin serial production in late Q3 2023 and be well positioned to take advantage of the recently announced initiatives under the Inflation Reduction Act. With that, I'll turn it back to Sascha to review the outlook.